Clinical trialNCT00336284CompletedPhase 4Interventional

TRUST: Lumos-T Safely RedUceS RouTine Office Device Follow-up

SponsorBiotronik, Inc.Enrollment1,450Patient Indicated for an ICD

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Niraj Varma, MD, FRCP
The Cleveland Clinic
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

110 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada

Site 104
Toronto, Ontario, Canada
Site 92
Fleurimont, Quebec, Canada

United States

Site 55
Birmingham, Alabama, United States
Site 68
Mesa, Arizona, United States
Site 99
Phoenix, Arizona, United States
Site 118
Bakersfield, California, United States
Site 91
Bakersfield, California, United States
Site 95
Burbank, California, United States
Site 72
Fairfield, California, United States
Site 43
Fremont, California, United States
Site 73
Fresno, California, United States
Site 75
Fresno, California, United States
Site 90
Fresno, California, United States
Site 67
Glendale, California, United States
Site 82
Jackson, California, United States
Site 78
Mission Viejo, California, United States
Site 15
Sherman Oaks, California, United States
Site 89
Simi Valley, California, United States
Site 88
Whittier, California, United States
Site 37
Boulder, Colorado, United States
Site 38
Boulder, Colorado, United States
Site 98
Denver, Colorado, United States
Site 122
Newark, Delaware, United States
Site 100
Brooksville, Florida, United States
Site 111
Jacksonville, Florida, United States
Site 40
Lakeland, Florida, United States
Site 36
Lauderdale Lakes, Florida, United States
Site 34
Miami, Florida, United States
Site 42
Oakland Park, Florida, United States
Site 13
Port Charlotte, Florida, United States
Site 41
Tamarac, Florida, United States
Site 60
Vero Beach, Florida, United States
Site 6
Canton, Georgia, United States
Site 106
Douglas, Georgia, United States
Site 61
Lawrenceville, Georgia, United States
Site 10
Marietta, Georgia, United States
Site 66
Marietta, Georgia, United States
Site 124
Chicago, Illinois, United States
Site 21
Chicago, Illinois, United States
Site 39
Oak Lawn, Illinois, United States

70 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Nov 2005
Primary completion: 30 Jun 2009
Completion: 30 Jun 2009
Last update posted: 3 Aug 2010
Registered enrollment: 1,450
Registry id: NCT00336284

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.